Levothyroxine Sodium Tablet
Product Images NDC 51655-728

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Levothyroxine Sodium (NDC 51655-728). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51655 728 52 Master Bottle Label Approval Rev A 06 21)

Label (51655 728 52 Master Bottle Label Approval   Rev A 06 21)
Levothyroxine Sodium Tablets, USP, in the strength of 88 mcg (0.088 mg) with NDC number 51655-728-52, and 30 tablets per bottle, is a prescription medicine. The medication is recommended according to the package insert. It should be stored at controlled room temperature between 59-86°F (15-30°C) and kept away from moisture and light. The package must be kept out of the reach of children. The medication is repackaged from the Lot number 0527-3283-XX by Northwind Pharmaceuticals with Expiration of 00/00/0000. The Global Trade Identification Number (GTIN) for the package is 0351655728529.*
FDA Label Image

Levothyroixe Molecule (Levothyroxine Molecule)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.